Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Background. Few data are available on quarterly 11.25 mg GnRH analog treatment in central precocious puberty (CPP). Aim. To assess the efficacy of triptorelin 11.25 mg in children with CPP. Patients. 17 patients (16 females) with CPP (7.9±0.9 years) were treated with triptorelin 11.25 mg/90 days. Me...

Full description

Bibliographic Details
Main Authors: Elena Chiocca, Eleonora Dati, Giampiero I. Baroncelli, Alessandra Cassio, Malgorzata Wasniewska, Fiorella Galluzzi, Silvia Einaudi, Marco Cappa, Gianni Russo, Silvano Bertelloni
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/583751

Internet

http://dx.doi.org/10.1100/2012/583751

Similar Items